Remove deals on-sale
article thumbnail

2025 Could See Uptick in Hospice M&A, Less ‘Deal Fatigue’

Hospice News

Hospices seeking a potential sale have varying “playbooks” for how a deal is structured, weighing many operational and financial considerations alongside care delivery impacts, Warren said at the National Association for Home Care & Hospice’s (NAHC) Financial Management Conference in Las Vegas.

2025 291
article thumbnail

[UPDATED] Enhabit Will Remain a Standalone Business

Hospice News

(NYSE: EHAB) will continue to operate as a stand-alone company instead of pursuing a sale. The review focused heavily on a potential sale, but, ultimately, Enhabit received no formal proposals for a transaction. AREX was motivated in part by recent, massive deals involving similar companies. Enhabit in Q4 2023 brought in $260.6

2023 265
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enhabit CEO: Discussions of Potential Sale Ongoing

Hospice News

(NYSE: EHAB) is in talks with interested parties about a possible forthcoming sale. s hospice business, though the company had no further updates on its planned “strategic alternatives,” which could include a sale. AREX was motivated in part by recent, massive deals involving similar companies.

2024 260
article thumbnail

Amedisys Expects to Close UnitedHealth Group Deal By Q4

Hospice News

Last week, Amedisys announced the sale of the locations to the home health and hospice provider VitalCaring for an undisclosed amount, according to a filing with the U.S. VitalCaring also acquired some Unitedhealth Group (NYSE: UNH) care centers in the deal. A federal court eventually allowed that deal to proceed.

2023 290
article thumbnail

The Most Significant Hospice Deals So Far in 2023

Hospice News

The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among the most common types of transactions. The majority of the 13 publicly announced hospice and home health deals in 2023 have involved “bolt-ons,” or smaller entities, Kulik stated. A number of trends have shifted.

2023 279
article thumbnail

Amedisys Shareholders Approve Sale to Optum

Hospice News

Optum in June penned a deal to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 More than 25 million stockholders voted in favor of the deal, with close to 30,000 against, according to an SEC filing released today. This is the second massive home health and hospice deal for Optum.

Medicare 297
article thumbnail

Enhabit Begins Mulling Strategic Alternatives, Possible Sale

Hospice News

NYSE: EHAB) has confirmed that it will begin considering “strategic alternatives” that could include a potential sale or merger. Discussions of a potential sale or merger have been tied to uneven quarterly financial results. Discussions of a potential sale or merger have been tied to uneven quarterly financial results.

2021 246